Activating point alterations represent another significant oncogenic mutation associated with inherited diseases such as multiple endocrine neoplasia 2A (MEN2A), multiple endocrine neoplasia 2B (MEN2B), and familial medullary thyroid carcinomas. The gene discussed is RET; the disease is multiple endocrine neoplasia type 2.